AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat a⦠read more
Healthcare
Drug ManufacturersāGeneral
12 years
USD
Exclusive to Premium users
$208.36
Price+0.39%
$0.81
$368.080b
Large
98.8x
Premium
Premium
+14.5%
EBITDA Margin+6.1%
Net Profit Margin+9.1%
Free Cash Flow Margin$58.328b
+3.5%
1y CAGR+0.3%
3y CAGR+1.0%
5y CAGR$3.769b
-11.9%
1y CAGR-27.6%
3y CAGR-20.1%
5y CAGR$2.11
-11.7%
1y CAGR-27.6%
3y CAGR-20.0%
5y CAGR$1.462b
$136.165b
Assets$134.703b
Liabilities$69.889b
Debt51.3%
5.8x
Debt to EBITDA$15.385b
-13.7%
1y CAGR-14.0%
3y CAGR-7.9%
5y CAGR